COSIBELIMAB, AN ANTI-PD-L1 ANTIBODY: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM A GLOBAL, MULTICOHORT PHASE 1 CLINICAL TRIAL

被引：2

作者：

Harris, Dean ^{[1
]}

Brungs, Daniel ^{[2
]}

Ladwah, Rahul ^{[3
]}

Mant, Andrew ^{[4
]}

McGrath, Margaret ^{[5
]}

Tazbirkova, Andrea ^{[6
]}

Akopov, Andrey ^{[7
]}

Fadeeva, Natalia ^{[8
]}

Kasparov, Boris ^{[9
]}

Kovalenko, Nadezhda ^{[10
]}

Kozlov, Vadim ^{[11
]}

Moiseenko, Fedor ^{[12
]}

Oschepkov, Vasiliy ^{[13
]}

Koralewski, Piotr ^{[14
]}

Kowalski, Dariusz ^{[15
]}

Lugowska, Iwona ^{[15
]}

Charoentumn, Chaiyut ^{[16
]}

Dechaphunkul, Arunee ^{[17
]}

Sriuranpong, Virote ^{[18
]}

Oliviero, James ^{[19
]}

Clingan, Philip ^{[2
]}

机构：

[1] Christchurch Hosp, Christchurch, New Zealand

[2] Southern Med Day Care Ctr, Wollongong, NSW, Australia

[3] Princess Alexandra Hosp, Woolloongabba, Qld, Australia

[4] Eastern Hlth, Box Hill, Vic, Australia

[5] Greenslopes Private Hosp, Greenslopes, Australia

[6] Pindara Private Hosp, Benowa, Australia

[7] First St Petersburg State Med Univ, St Petersburg, Russia

[8] Chelyabinsk Reg Clin Oncol Ctr, Chelyabinsk, Russia

[9] NMRC Oncol, St Petersburg, Russia

[10] Volgograd Reg Clin Onc Dispensary, Volgograd, Russia

[11] Novosibirsk Reg Clin Onc Dispensary, Novosibirsk, Russia

[12] St Petersburg Clin Res & Pract Ctr, St Petersburg, Russia

[13] Multidisciplinary Clin Med Ctr, Tyumen, Russia

[14] Szpital Specjalistyczny Ludwika Rydygier, Krakow, Poland

[15] Natl Res Inst Oncol, Warsaw, Poland

[16] Maharaj Nakorn Chiang Mai Hosp, Chiang Mai, Thailand

[17] Prince Songkla Univ, Hat Yai, Thailand

[18] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[19] Checkpoint Therapeut, New York, NY USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷

关键词：

D O I：

10.1136/jitc-2020-SITC2020.0399

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

399

引用

页码：A242 / A243

页数：2